Literature DB >> 17558639

"Machiavellianism" and frontal dysfunction: evidence from Parkinson's disease.

Patrick McNamara1, Raymon Durso, Erica Harris.   

Abstract

INTRODUCTION: A number of reports have identified significant personality differences in patients with Parkinson's disease (PD) when compared with age-matched controls. We hypothesised that these differences may be related to impairment in prefrontal inhibitory functions resulting in the expression of new "Machiavellian" personality traits.
METHODS: Thirty-five patients with PD and 17 age-matched controls were assessed with a set of neuropsychologic, personality and mood tests as well as the Mach IV scale, which measures a set of "Machiavellian" personality characteristics.
RESULTS: PD patients with elevated Machiavellian traits ("high Machs") were selectively impaired on tests of prefrontal function relative to "low Mach" patients. In addition, while high Machs did not differ from low Machs in terms of age, educational level, Hoehn-Yahr stage, mood function, or Mini Mental State Exam score, they indicated greater willingness to affiliate with a fictional Machiavellian character and scored significantly lower on the "cooperativeness" and "self-directedness" subscales of the Cloninger Temperament and Character Inventory.
CONCLUSIONS: We suggest that (1) PD patients with frontal impairment are vulnerable to dramatic personality change, and (2) the frontal lobes are required for maintenance of prosocial personality traits.

Entities:  

Mesh:

Year:  2007        PMID: 17558639     DOI: 10.1080/13546800701202316

Source DB:  PubMed          Journal:  Cogn Neuropsychiatry        ISSN: 1354-6805            Impact factor:   1.871


  10 in total

Review 1.  Impulse control disorders in Parkinson's disease: the role of personality and cognitive status.

Authors:  Michele Poletti; Ubaldo Bonuccelli
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

2.  Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson's disease.

Authors:  Harpreet Kaur; Shaveta Chauhan; Rajat Sandhir
Journal:  Neurochem Res       Date:  2011-04-12       Impact factor: 3.996

Review 3.  Personality traits in patients with Parkinson's disease: assessment and clinical implications.

Authors:  Michele Poletti; Ubaldo Bonuccelli
Journal:  J Neurol       Date:  2011-11-15       Impact factor: 4.849

4.  Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson's disease.

Authors:  Ana Navarro; Alberto Boveris
Journal:  Front Aging Neurosci       Date:  2010-09-01       Impact factor: 5.750

Review 5.  Brain mitochondrial dysfunction and oxidative damage in Parkinson's disease.

Authors:  Ana Navarro; Alberto Boveris
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

6.  Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging.

Authors:  Cristina Nombela; Pedro J Bustillo; Pedro F Castell; Lucía Sanchez; Vicente Medina; María Trinidad Herrero
Journal:  Front Neurol       Date:  2011-12-22       Impact factor: 4.003

7.  An Increase of the Character Function of Self-Directedness Is Centrally Involved in Symptom Reduction during Remission from Major Depression.

Authors:  Jaap G Goekoop; Remco F P De Winter; Rutger Goekoop
Journal:  Depress Res Treat       Date:  2011-11-24

8.  Stable self-serving personality traits in recreational and dependent cocaine users.

Authors:  Boris B Quednow; Lea M Hulka; Katrin H Preller; Markus R Baumgartner; Christoph Eisenegger; Matthias Vonmoos
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

9.  The sense-of-coherence predicts health-related quality of life and emotional distress but not disability in Parkinson's disease.

Authors:  Annalisa Gison; Federica Rizza; Stefano Bonassi; Valentina Dall'Armi; Stefania Lisi; Salvatore Giaquinto
Journal:  BMC Neurol       Date:  2014-10-10       Impact factor: 2.474

10.  Neuroticism, Smoking, and the Risk of Parkinson's Disease.

Authors:  Johanna Sieurin; Yiqiang Zhan; Nancy L Pedersen; Karin Wirdefeldt
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.